Introduction
Methods
Case report
Systematic review
Search strategy and data collection
Results
First author (year of publication) | Number of patients | Indication | RT-technique | Prescription (total dose/single dose/schedule) | Follow-up | Outcome |
---|---|---|---|---|---|---|
Shneerson (1980) [15] | 1 | Hemoptysis due to aspergilloma | 2D conventional; single anterior field initially/parallel opposed fields for relapse | Initially: 20 Gy/4 Gy/7 days Relapse after 8 weeks: additional 10 Gy/2 Gy/7 days | 8 months | No further bleeding during follow-up and stable size of aspergilloma |
Sahoo (1989) [16] | 3 | Palliative RT for bronchogenic carcinoma in patients with positive Aspergillus antibodies | NR | 30 Gya/NR/6 weeks | NR | Disappearance of Aspergillus antibodies/seroconversion |
Sahoo (1990) [17] | 1 | Palliative RT for bronchogenic carcinoma in patient with concurrent TB and positive Aspergillus antibodies | NR | 30 Gya/NR/NR with concomitant antituberculosis chemotherapy | 5 months | Disappearance of Aspergillus antibodies/seroconversion |
Fernandez Vazquez (1994) [12] | 1 | Hemoptysis due to aspergilloma with underlying TB | NR | 30 Gy/NR/NR | NR | No further bleeding reported |
Falkson (2002) [18] | 5 | Hemoptysis due to aspergilloma | 2D conventional; anterior–posterior parallel opposed fields with 1.0 cm margin | 7–14 Gy/3.5 Gy/once weekly, one additional fraction after hemoptysis stopped | 6 months | No further bleeding during follow-up |
Glover (2007) [19] | 1 | Hemoptysis due to aspergilloma with underlying small vessel vasculitis | NR | 8 Gy/4 Gy/10 days apart | 6 months | No further bleeding during follow-up and radiographic resolution of aspergilloma |
Samuelian (2011) [20] | 1 | Hemoptysis due to aspergilloma | 2D conventional; anterior–posterior parallel opposed fields with 1.5 cm margin | 28 Gy/3.5 Gy/once weekly | 4 years | Hemoptysis resolved after 8 weeks; only clinically insignificant hemoptysis during follow-up; aspergilloma decreased in size |
Sapienza (2015) [13] | 21 | Hemoptysis due to aspergilloma with underlying TB | 2D conventional; parallel opposed fields with 1.0–2.0 cm margins | Initially: 20 Gy/2 Gy/daily Persistence (one patient): additional 14 Gy/2 Gy/daily Recurrence (one patient): additional 20 Gy/2 Gy/daily | Mean 73.5 months (1.3–281 months) | 5‑year local control: 82% 5‑year overall survival: 59% Two patients died due to recurrence of hemoptysis |
Bastin (2020) [14] | 1 | Hemoptysis due to aspergilloma | 3D conformal; opposed-oblique fields with 1 cm CTV and 1 cm PTV margin | 7 Gy/3.5 Gy/once weekly | > 7 months (plus several months, not specified) | Patient died due to recurrence of hemoptysis |
Current case | 1 | Hemoptysis due to aspergilloma | SBRT | 16 Gy/8 Gy/daily | 6 years | Decrease in hemoptysis frequency with only clinically insignificant hemoptysis. No further bleeding in last 3 years |